851627-80-0

851627-80-0 structure

Name: PR-104 sodium
Chemical Name: Sodium 2-({2-[(2-bromoethyl){2-[(methylsulfonyl)oxy]ethyl}amino]- 3,5-dinitrobenzoyl}amino)ethyl hydrogen phosphate
CAS Number: 851627-80-0
Molecular Formula: C₁₄H₁₉BrN₄NaO₁₂PS
Molecular Weight: 601.25300
Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA Alkylator/Crosslinker
Create Date: 2016-05-18 07:21:54
Modify Date: 2024-01-10 16:55:03
PR-104 (sodium) is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104 (sodium), as a nitrogen mustard pre-prodrug, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A[1].

Name	Sodium 2-({2-[(2-bromoethyl){2-[(methylsulfonyl)oxy]ethyl}amino]- 3,5-dinitrobenzoyl}amino)ethyl hydrogen phosphate

Description	PR-104 (sodium) is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104 (sodium), as a nitrogen mustard pre-prodrug, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> DNA Alkylator/Crosslinker
In Vitro	PR-104 (sodium) (80 μM; 1 hour; SiHa cells) shows greater suppression of radiation-induced DNA single-strand breaks under hypoxic than aerobic conditions. PR-104 (sodium) (100 μM; 1 hour; SiHa cells) results in phosphorylation of Ser139 of histone H2AX (gH2AX). PR-104 (sodium) (0.266 mmol/kg; 18 h; SiHa cells) shows activity against hypoxic cells after irradiation. PR-104 (sodium) varies in potency between cell lines, with the lowest IC50 (0.51 μmol/L) in H460 cells and highest (7.3 μmol/L) in PC3 prostate cells[1].
In Vivo	PR-104 (sodium) (0.56 mmol/kg; i.v. or i.p.; 0~2 hours) makes the plasma area under the curve. PR-104 (sodium) (0.23 mmol/kg; i.p.; 100 days) shows antitumor activity[1]. Animal Model: CD-1nu/nu mice Dosage: 0.56 mmol/kg (Pharmacokinetics Analysis) Administration: I.v. or i.p. Result: The plasma area under the curve. Animal Model: CD1-Foxn1nu mice Dosage: 0.23 mmol/kg Administration: I.p. Result: Showed antitumor activity.
References	[1]. Patterson AV, et al. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104. Clin Cancer Res. 2007;13(13):3922-3932.

Molecular Formula	C₁₄H₁₉BrN₄NaO₁₂PS
Molecular Weight	601.25300
Exact Mass	599.95400
PSA	258.62000
LogP	3.09410

851627-80-0	851627-62-8
211915-06-9	34487-61-1
78456-94-7	85408-09-9
99026-78-5	14394-29-7
71872-95-2	1192491-61-4
1158522-08-7	1252825-91-4
940364-43-2	1251568-21-4
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1251678-95-1	1018584-77-4